Archit Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 07-12-2024
- Paid Up Capital ₹ 2.48 M
as on 07-12-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.07 Cr
as on 07-12-2024
- Satisfied Charges ₹ 3.34 Cr
as on 07-12-2024
- Revenue -33.22%
(FY 2021)
- Profit -26.00%
(FY 2021)
- Ebitda -37.91%
(FY 2021)
- Net Worth 5.15%
(FY 2021)
- Total Assets -34.07%
(FY 2021)
About Archit Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.48 M.
The company currently has active open charges totaling ₹2.07 Cr. The company has closed loans amounting to ₹3.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arash Dhawan and Alka Dhawan serve as directors at the Company.
- CIN/LLPIN
U24116DL1999PTC098044
- Company No.
098044
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Archit Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arash Dhawan  | Director | 23-Jan-1999 | Current |
| Alka Dhawan | Director | 23-Jan-1999 | Current |
Financial Performance and Corporate Structure Insights of Archit Chemicals.
Archit Chemicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 33.22% decrease. The company also saw a substantial fall in profitability, with a 26% decrease in profit. The company's net worth moved up by a moderate rise of 5.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Archit Chemicals?
In 2021, Archit Chemicals had a promoter holding of 68.95% and a public holding of 31.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jld Builders And Developers Private LimitedActive 13 years 11 months
Arash Dhawan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 May 2022 | ₹0.70 M | Open |
Hdfc Bank Limited Creation Date: 31 Mar 2018 | ₹2.00 Cr | Open |
Icici Bank Limited Creation Date: 02 Feb 2013 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Archit Chemicals?
Archit Chemicals has a workforce of 9 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Archit Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Archit Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
